Prosecution Insights
Last updated: October 25, 2026

Wood, Phillips, Katz, Clark & Mortimer

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

74 pending office actions • 56 clients • 71 examiners • 55 art units • 0 of 74 (0%) have an AI response strategy ready • 101 patents granted in the last 365 days

Analysis

WOOD, PHILLIPS, KATZ, CLARK & MORTIMER has 70 pending office actions in Biotechnology & Pharmaceuticals and 5379 career applications. Its resolved allowance rate is 78.84%, with an average of 3.06 office actions per allowance.

The profile shows an active biotechnology and pharmaceutical docket supported by a substantial application base. The allowance rate provides a resolved-outcome measure, while the office-action average indicates that allowed matters commonly require multiple examination exchanges. Practitioners can use these figures to frame workload and response planning involving biological disclosure, therapeutic applications, and claim support. The aggregate data does not identify the rejection types or technologies responsible for individual results.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=5379 apps, methodology: how we score firms)

78.8%
Allowance Rate
n=5379
+0.54σ
Allowance Rate (norm)
n=5379
3.1
OAs to Allowance
n=3088
-0.22σ
OAs to Allow (norm)
n=3088
1096 days
Time to Allowance
n=3088
+11.7pp
Interview Lift
n=5379
21.4%
RCE Rate
n=5379
2.9%
Appeal Rate
n=5379

Rejection Performance (% of received rejections ultimately overcome)

71.2%
§101 Overcome
n=191
75.3%
§102 Overcome
n=1132
76.0%
§103 Overcome
n=1821
77.0%
§112 Overcome
n=1302

Specialization & Scale

A61K, A01N, B65D
Top CPC Subclasses
15%
Top-3 CPC Share
n=5379
2
Practitioners
n=5379
2689.5
Apps / Practitioner
n=5379

Portfolio Summary

74
Total Pending OAs
47
Non-Final OAs
25
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 22 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

14
Overdue
0
Due this week
5
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 22 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (14)Due ≤ 30 days (5)Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

40
Hard (54%)
30
Medium (41%)
3
Easy (4%)
1
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only2 (3%)
§101 + other4 (5%)
§103 only20 (27%)
§102 only3 (4%)
§112 only2 (3%)
Double-patenting only1 (1%)
Double-patenting + other7 (9%)
Multi-statute (no §101)34 (46%)
No statute on record1 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

40
Life Sciences
54% of docket
2
Information Tech
3% of docket
1
Communications
1% of docket
2
Semiconductors
3% of docket
27
Mechanical / Eng
36% of docket
2
Business / Other
3% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

740 h
Manual time on pending OAs
148 h
Time saved (low, 20%)
259 h
Time saved (mid, 35%)
6.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MUTCHLER, CHRISTOPHER JOHN 2 55.7% +22.7%
HAGOPIAN, CASEY SHEA 2 54.3% +33.4%
HAGHIGHATIAN, MINA 2 46.0% +39.4%
MCGRATH, ERIN E 1 60.3% +28.4%
ATKINSON, JOSHUA ALEXANDER 1 51.8% +27.5%
ACKUN, JACOB K 1 57.1% +3.3%
MOORE, ZACHARY T 1 71.9% +36.1%
AURORA, REENA 1 87.1% -13.3%
COOLEY, CHARLES E 1 79.0% +15.3%
MCDUFFIE, MICHAEL D 1 67.7% -10.5%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18290141 A Probe Card Stroke Compensation System and Method AURORA, REENA —

Hard Cases (40)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18565915 VISUAL PROTECTION DEVICE FOR TASK FORCES FISSEL, TRAVIS S 59d overdue
17623554 INHALABLE COMPOSITION COMPROMISING CYCLODEXTRIN FOR USE IN THE TREATMENT OF NASAL INFLAMMATIONS BRANDSEN, BENJAMIN MICHAEL 8d overdue
18697727 NOVEL PROBIOTICS AND USE THEREOF ARMATO JR, DENNIS IGNATIUS 20d
18204867 METHOD OF ASSEMBLING CONDUIT SECTIONS LEGASPI, EUGENE REY DEVERA 22d
18563681 USER INTERFACE WHICH INDUCES MACHINE OPERATOR INTERACTION AND EFFICIENCIES FOLLANSBEE, YVONNE TRANG 26d
17389556 ANTI-VIRAL COMPOSITIONS AND METHODS OF USE THEREOF MERCIER, MELISSA S 56d
18700205 MEDICAL WATCH FOR MEASURING PHYSIOLOGICAL PARAMETERS PAHAKIS, MANOLIS Y 82d
19172028 METHOD FOR THE TREATMENT OF MALARIA MUTCHLER, CHRISTOPHER JOHN —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17699405 LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF HAGHIGHATIAN, MINA 267d overdue
17405773 LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF HAGHIGHATIAN, MINA 267d overdue
16852870 MIXTURES OF SABADILLA ALKALOIDS AND PYRETHROIDS AND USES THEREOF HAGOPIAN, CASEY SHEA 70d
19172028 METHOD FOR THE TREATMENT OF MALARIA MUTCHLER, CHRISTOPHER JOHN —
19113613 SURGICAL APPARATUS AND METHOD OF USE MCGRATH, ERIN E —
19080145 AMINOETHOXYVINYLGLYCINE AND 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND USES THEREOF ATKINSON, JOSHUA ALEXANDER —
19072779 MOVABLE AND STACKABLE BASE FOR EXERCISE EQUIPMENT MOORE, ZACHARY T —
19047191 MIXING AND KNEADING MACHINE COOLEY, CHARLES E —

Client Portfolio (56 clients)

View all 56 →

Top Art Units

Art UnitApps
16177
37964
16573
37712
16122
17642
37832
16332
16382
16162

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19172028 METHOD FOR THE TREATMENT OF MALARIA Instituto De Investigaciones Cientificas Y Servicios De Alta Technologia MUTCHLER, CHRISTOPHER JOHN 3796 §102§103 Non-Final OA — Pending Apr 07, 2025
19113613 SURGICAL APPARATUS AND METHOD OF USE Nallakrishnan Family Trust MCGRATH, ERIN E 3771 §102§103§112 Non-Final OA — Pending Mar 20, 2025
19080145 AMINOETHOXYVINYLGLYCINE AND 1-AMINO-1-CYCLOPROPANECARBOXYLIC ACID AND USES THEREOF Valent Biosciences LLC ATKINSON, JOSHUA ALEXANDER 1612 §103§112 Non-Final OA — Pending Mar 14, 2025
19110736 UTILITY CONNECTIVITY SYSTEM Keter Home And Garden Products Ltd. ACKUN, JACOB K 3736 §103§112 Non-Final OA — Pending Mar 11, 2025
19072779 MOVABLE AND STACKABLE BASE FOR EXERCISE EQUIPMENT Heart Rate Inc. MOORE, ZACHARY T 3784 §103§112 Non-Final OA — Pending Mar 06, 2025
18290141 A Probe Card Stroke Compensation System and Method Shanghai Zenfocus Semi-Tech Co., Ltd. AURORA, REENA 2858 §112 Non-Final OA — Pending Feb 06, 2025
19047191 MIXING AND KNEADING MACHINE Buss AG COOLEY, CHARLES E 1774 §103 Final Rejection — Pending Feb 06, 2025
19045529 ENDOSCOPE VISUAL FIELD-SECURING VISCOELASTIC COMPOSITION Otsuka Pharmaceutical Factory, Inc. HAGOPIAN, CASEY SHEA 1617 §102§103§112 Non-Final OA — Pending Feb 04, 2025
19044281 METHOD AND ASSEMBLY FOR DISPLAYING AND SECURING A WEARABLE DEVICE AGAINST THEFT Se-Kure Controls, Inc. MCDUFFIE, MICHAEL D 4100 §102§103 Non-Final OA — Pending Feb 03, 2025
19099977 PAIR OF GOGGLES FOR ANIMALS OF THE EQUINE SPECIES Equidiva ALMATRAHI, SAHAR FARIS 3643 §102§103§112 Final Rejection — Pending Jan 30, 2025
18997448 DISPENSING CLOSURE FOR A CONTAINER AND CONTAINER WITH SUCH A DISPENSING CLOSURE Aptar Freyung GmbH LONG, DONNELL ALAN 3754 §102§103 Non-Final OA — Pending Jan 21, 2025
18877811 CHAIR Keter Home And Garden Products Ltd. ALEKSIC, NEVENA 3647 §102§103 Non-Final OA — Pending Dec 20, 2024
18970140 PIVOTAL SLEIGH SHOVEL Inotev Inc. TSUI, ALFRED H 3671 §102 Non-Final OA — Pending Dec 05, 2024
18968452 RESEALABLE, REUSABLE, RECYCLABLE SECONDARY PACKAGING TRANSPORT BAG Petoskey Plastics HELVEY, PETER N. 3734 §103 Non-Final OA — Pending Dec 04, 2024
18962574 MOUNTING BRACKET FOR ELECTRICAL BOX S-P Products, Inc. HOLLY, LEE A 3726 §102 Non-Final OA — Pending Nov 27, 2024
18944146 (S)-ABSCISIC ACID FOR REDUCING FRUIT DROP Valent Biosciences LLC CONIGLIO, AUDREA JUNE BUCKLEY 1617 §103§112 Non-Final OA — Pending Nov 12, 2024
18860530 A GARMENT ASSEMBLY FOR TRIGGERING, FACILITATING OR RESISTING MOVEMENT Dennisson Technologies Limited HURLEY, SHAUN R 3732 §103 Non-Final OA — Pending Oct 25, 2024
18849303 HOLDING PLATE FOR MULTIPLE SCREW DIAMETERS Ejot SE & Co. Kg MCCALISTER, WILLIAM M 3753 §103§112 Non-Final OA — Pending Sep 20, 2024
18888671 METHOD FOR TRAINING AUTONOMOUS DRIVING MODEL, METHOD FOR PREDICTING AUTONOMOUS DRIVING VIDEO, ELECTRONIC DEVICE, AND STORAGE MEDIUM Shanghai Artificial Intelligence Innovation Center TSAI, TSUNG YIN 2656 §102§103 Non-Final OA — Pending Sep 18, 2024
18887617 SAFETY SYSTEM FOR FIRE EXTINGUISHERS Se-Kure Controls, Inc. BOECKMANN, JASON J 3752 §102§103 Final Rejection — Pending Sep 17, 2024
18776542 THERMAL CLEANING AND DISINFECTING DEVICE W & H Sterilization S.r.l. PILSBURY, BRADY CHARLES 1799 §102§103§112 Non-Final OA — Pending Jul 18, 2024
18729261 DOMESTIC APPLIANCE FOR DISPENSING DRINKING WATER Buse Ksw GmbH & Co. Kg PATEL, PRANAV N 1779 §103§112 Non-Final OA — Pending Jul 16, 2024
18723782 EDGE FUNCTIONALISED GRAPHENE THERMAL NANOFLUIDS Sicona Battery Technologies Pty Ltd., NGUYEN, TRI V 1764 §103 Non-Final OA 9d overdue Pending Jun 24, 2024
18720436 NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF Ildong Pharmaceutical Co., Ltd. NOTTINGHAM, KYLE GREGORY 1621 §103DP Non-Final OA — Pending Jun 14, 2024
18716367 FASTENING SYSTEM AND METHOD FOR MOUNTING IN A SUBSTRATE Ejot SE & Co. Kg MAGAR, DIL KUMAR 3675 §102§103 Non-Final OA — Pending Jun 04, 2024
18714529 A DEVICE FOR AFFECTING VASCULAR BLOOD FLOW AND METHODS THEREOF Novapulse Ltd. GROSS, JASON PATRICK 3797 §103 Non-Final OA 30d overdue Pending May 29, 2024
18677604 MOUNTING STRIP Slide2Seal Ltd. LEE, MICHAEL S 3677 §103 Final Rejection 36d overdue Pending May 29, 2024
18713073 Surgical Apparatus Nallakrishnan Family Trust RITCHIE, HADEN MATTHEW 3783 §103 Non-Final OA — Pending May 23, 2024
18669120 DISTRIBUTED MODEL TRAINING METHOD, DEVICE, AND MEDIUM Shanghai Artificial Intelligence Innovation Center ALI, NAYMUR RAHMAN 2123 §101§103§112 Non-Final OA — Pending May 20, 2024
18711487 METHOD FOR ISOLATING, MAINTAINING, PROLIFERATING, AND DIFFERENTIATING MONOCLONAL CELLS DERIVED FROM HUMAN SALIVARY GLAND EPITHELIAL STEM CELLS OR PROGENITOR CELLS AND PRODUCTION METHOD FOR EXTRACELLULAR VESICLES FOR TREATING SALIVARY GLAND DISEASES Industry-Academic Cooperation Foundation, Yonsei University SMALL, KATHERINE R 1633 §102§103 Non-Final OA — Pending May 17, 2024
18663567 STONE FRUIT QUALITY Valent Biosciences LLC DIOU BERDECIA, LUIS EUGENIO 1792 §103§112 Final Rejection — Pending May 14, 2024
18705431 TISSUE-SPECIFIC PROMOTER AND USE THEREOF BEIJING MEIKANG GENO-IMMUNE BIOTECHNOLOGY CO., LTD. ROGERS, ERIC JASON 1638 §103§112 Non-Final OA — Pending Apr 26, 2024
18700205 MEDICAL WATCH FOR MEASURING PHYSIOLOGICAL PARAMETERS Cardiacsense Ltd. PAHAKIS, MANOLIS Y 3796 §103§112 Non-Final OA 82d Pending Apr 10, 2024
18697727 NOVEL PROBIOTICS AND USE THEREOF Nvp Healthcare Co., Ltd. ARMATO JR, DENNIS IGNATIUS 1651 §103§112 Non-Final OA 20d Pending Apr 01, 2024
18688155 Surgical Apparatus Nallakrishnan Family Trust LABRANCHE, BROOKE N 3771 §102§103 Final Rejection — Pending Feb 29, 2024
18293154 PHACOEMULSIFICATION NEEDLE Raico International, LLC DIOP, FATIMATA SAHRA 3783 §103 Non-Final OA — Pending Jan 29, 2024
18420254 DISPLAY WITH REFLECTIVE SURFACE Se-Kure Controls, Inc. LEWIS, JUSTIN V 3637 §103 Final Rejection — Pending Jan 23, 2024
18571648 LEPTIN RECEPTOR AFFINITY PEPTIDE AND USE THEREOF Dubu Biosciences BORGEEST, CHRISTINA M 1675 §101§103§112 Non-Final OA — Pending Dec 18, 2023
18565915 VISUAL PROTECTION DEVICE FOR TASK FORCES Rubi Glas GmbH FISSEL, TRAVIS S 2872 §102§112 Final Rejection 59d overdue Pending Nov 30, 2023
18565473 STATEMENT BLOCK ENCAPSULATION METHOD AND APPARATUS, ELECTRONIC DEVICE, AND STORAGE MEDIUM S2C Limited LIN, ARIC §101 Non-Final OA — Pending Nov 29, 2023
18563681 USER INTERFACE WHICH INDUCES MACHINE OPERATOR INTERACTION AND EFFICIENCIES Fellowes, Inc. FOLLANSBEE, YVONNE TRANG 2117 §102§103 Final Rejection 26d Pending Nov 22, 2023
18288160 SYSTEM FOR SUPERVISION OF THE OPERATION AND MAINTENANCE OF INDUSTRIAL EQUIPMENT Seadvance SIMPSON, DIONE N 3629 §101 Non-Final OA — Pending Oct 24, 2023
18287843 METHOD, SYSTEM AND ELECTRONIC WEARABLE UNIT FOR CONTROLLING ELECTRICAL STIMULATION TO PELVIC REGION OF A SUBJECT Indian Institute Of Science TEHRANI, DANIEL 3792 §102§103 Non-Final OA — Pending Oct 20, 2023
18284252 COLORIMETRIC BIOSENSOR, PREPARATION METHOD THEREOF, AND ANTIBIOTIC SUSCEPTIBILITY TESTING METHOD USING THE SAME Inha University Research And Business Foundation BREEN, KIMBERLY CATHERINE 1657 §103 Final Rejection — Pending Sep 26, 2023
18283424 SPIRULINA-BASED COMPOSITION AND USES THEREOF FOR REINFORCING IMMUNITY Axeen Pharma AFREMOVA, VERA 1653 §102§103§112 Final Rejection — Pending Sep 21, 2023
18463497 HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF Valent U.S.A. LLC MEYERS, ELIZABETH ANNE 1617 §103DP Non-Final OA — Pending Sep 08, 2023
18277511 KIT FOR TREATING DAMAGED NERVES Reddress Ltd. ALTER MORSCHAUSER, ALYSSA MARGO 3796 DP Final Rejection 203d overdue Pending Aug 16, 2023
18275782 METHOD AND KIT FOR TREATING ABNORMAL HOLLOWED SPACE Reddress Ltd. BOECKELMAN, JACOB A 1655 §103§112 Final Rejection — Pending Aug 03, 2023
18270165 COMPOSITION FOR INHIBITING METASTASIS AND ENHANCING ANTICANCER DRUG SENSITIVITY Korea Advanced Institute Of Science And Technology GROOMS, TIFFANY NICOLE 1637 §103§112 Non-Final OA — Pending Jun 28, 2023
18204867 METHOD OF ASSEMBLING CONDUIT SECTIONS S-P Products, Inc. LEGASPI, EUGENE REY DEVERA 3729 §103§112 Non-Final OA 22d Pending Jun 01, 2023

View all 74 →

Managing Wood, Phillips, Katz, Clark & Mortimer's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Wood, Phillips, Katz, Clark & Mortimer's patent allowance rate?

78.8% of resolved applications prosecuted by Wood, Phillips, Katz, Clark & Mortimer were allowed, across 5,379 applications in USPTO records.

How many office actions does Wood, Phillips, Katz, Clark & Mortimer average before allowance?

3.06 office actions per allowed application on average.

How many pending office actions does Wood, Phillips, Katz, Clark & Mortimer have?

74 pending office actions as of October 2026, for 56 clients, before 71 examiners in 55 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month